Article Versions Notes

Laurent A, Abdel-Sayed P, Ducrot A, Hirt-Burri N, Scaletta C, Jaccoud S, Nuss K, de Buys Roessingh AS, Raffoul W, Pioletti D, et al. Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation. Biomolecules. 2021; 11(2):250. https://doi.org/10.3390/biom11020250

Laurent, Alexis, Philippe Abdel-Sayed, Aurélie Ducrot, Nathalie Hirt-Burri, Corinne Scaletta, Sandra Jaccoud, Katja Nuss, Anthony S. de Buys Roessingh, Wassim Raffoul, Dominique Pioletti, and et al. 2021. "Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation" Biomolecules 11, no. 2: 250. https://doi.org/10.3390/biom11020250

Laurent, A., Abdel-Sayed, P., Ducrot, A., Hirt-Burri, N., Scaletta, C., Jaccoud, S., Nuss, K., de Buys Roessingh, A. S., Raffoul, W., Pioletti, D., von Rechenberg, B., Applegate, L. A., & Darwiche, S. (2021). Development of Standardized Fetal Progenitor Cell Therapy for Cartilage Regenerative Medicine: Industrial Transposition and Preliminary Safety in Xenogeneic Transplantation. Biomolecules, 11(2), 250. https://doi.org/10.3390/biom11020250